Different roles for the Axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Schneikert, Jean ^a   Ruppert, Jan Gustav ^a   Behrens, Jürgen ^a   Wenzel, Eva Maria ^b,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APC LIKE PROTEIN; APC PROTEIN; AXIN; AXIN 2; BETA CATENIN; UNCLASSIFIED DRUG; APC PROTEIN, HUMAN; APC2 PROTEIN, HUMAN; AXIN1 PROTEIN, HUMAN; AXIN2 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; PROTEIN BINDING;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; DOWN REGULATION; GOLGI COMPLEX; OLIGOMERIZATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RGS DOMAIN; SAMP REPEAT; SECOND TWENTY AMINO ACID REPEAT; AMINO ACID SEQUENCE; BINDING SITE; CELL TRANSFORMATION; CHEMISTRY; COLON POLYPOSIS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; AXIN PROTEIN; BETA CATENIN; BINDING SITES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; CYTOSKELETON; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; REPETITIVE SEQUENCES, AMINO ACID; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 84899530105     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094413     Document Type: Article

References (71)

1. Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149: 1192-1205.
2. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, et al. (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642. (Pubitemid 26268958)
3. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, et al. (1996) XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86: 391-399. (Pubitemid 26272079)
4. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, et al. (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17: 1371-1384. (Pubitemid 28105516)
5. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
6. Ha NC, Tonozuka T, Stamos JL, Choi HJ, Weis WI (2004) Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Mol Cell 15: 511-521. (Pubitemid 39141779)
7. Xing Y, Clements WK, Le Trong I, Hinds TR, Stenkamp R, et al. (2004) Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function. Mol Cell 15: 523-533. (Pubitemid 39141780)
8. Roberts DM, Pronobis MI, Poulton JS, Waldmann JD, Stephenson EM, et al. (2011) Deconstructing the beta-catenin destruction complex: mechanistic roles for the tumor suppressor APC in regulating Wnt signaling. Mol Biol Cell 22: 1845-1863.
9. Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, et al. (2012) Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell 149: 1245-1256.
10. Yokoyama N, Yin D, Malbo CC (2007) Abundance, complexation, and trafficking of Wnt/beta-catenin signaling elements in response to Wnt3a. J Mol Signal: 2, e11.
11. Hilger M, Mann M (2012) Triple SILAC to determine stimulus specific interactions in the Wnt pathway. J Proteome Res 11: 982-994.
12. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600.
13. Schneikert J, Behrens J (2007) The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut 56: 417-425. (Pubitemid 46579774)
14. Day CL, Alber T (2000) Crystal structure of the amino-terminal coiled-coil domain of the APC tumor suppressor. J Mol Biol 301: 147-156.
15. Li Z, Kroboth K, Newton IP, Näthke IS (2008) Novel self-association of the APC molecule affects APC clusters and cell migration. J Cell Sci 121: 1916-1925. (Pubitemid 351943385)
16. Su LK, Vogelstein B, Kinzler KW (1993) Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737. (Pubitemid 24030097)
17. Eklof Spink K, Fridman SG, Weis WI (2001). Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex. EMBO J 20: 6203-6212. (Pubitemid 33078694)
18. Liu J, Xing Y, Hinds TR, Zheng J, Xu W (2006) The third 20 amino acid repeat is the tightest binding site of APC for beta-catenin. J Mol Biol 360: 133-144. (Pubitemid 43927813)
19. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, et al. (1993) Association of the APC gene product with beta-catenin. Science 262: 1731-1734. (Pubitemid 24030096)
20. Kohler EM, Chandra SH, Behrens J, Schneikert J (2009) Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours. Hum Mol Genet 18: 213-226.
21. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, et al. (1998) Functional interaction of an Axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596-599.
22. Spink KE, Polakis P, Weis WI (2000) Structural basis of the Axin-adenomatous polyposis coli interaction. EMBO J 19: 2270-2279. (Pubitemid 30259008)
23. McCartney B, Näthke IS (2008) Cell regulation by the Apc protein Apc as master regulator of epithelia. Curr Opin Cell Biol 20: 186-193.
24. Kohler EM, Brauburger K, Behrens J, Schneikert J (2010) Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients. Oncogene 29: 1663-1671.
25. Rubinfeld B, Albert I, Porfiri E, Munemitsu S, Polakis P (1997) Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res 57: 4624-4630. (Pubitemid 27441070)
26. Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, et al. (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337.
27. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, et al. (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1: 229-233.
28. Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, et al. (2000) APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci USA 97: 3352-3357. (Pubitemid 30183306)
29. Rosin-Arbesfeld R, Cliffe A, Brabletz T, Bienz M (2003) Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription. EMBO J 22: 1101-1113. (Pubitemid 36313594)
30. Kohler EM, Derungs A, Daum G, Behrens J, Schneikert J (2008) Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours. Hum Mol Genet 17: 1978-1987. (Pubitemid 351865846)
31. Schneikert J, Brauburger K, Behrens J (2011) APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerisation of truncated APC. Hum Mol Genet 20: 3554-3564.
32. Kawasaki Y, Senda T, Ishidate T, Koyama R, Morishita T, et al. (2000) Asef, a link between the tumor suppressor APC and G-protein signaling. Science 289: 1194-1197. (Pubitemid 30650732)
33. Jimbo T, Kawasaki Y, Koyama R, Sato R, Takada S, et al. (2002) Identification of a link between the tumour suppressor APC and the kinesin superfamily. Nat Cell Biol 4: 323-327. (Pubitemid 34308860)
34. Watanabe T, Wang S, Noritake J, Sato K, Fukata M, et al. (2004) Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin filaments during cell polarization and migration. Dev Cell 7: 871-883. (Pubitemid 39654731)
35. Major MB, Camp ND, Berndt JD, Yi X, Goldenberg SJ, et al. (2007) Wilms tumor suppressor WTX negatively regulates Wnt/beta-catenin signaling. Science 316: 1043-1046. (Pubitemid 46799493)
36. Grohmann A, Tanneberger K, Alzner A, Schneikert J, Behrens J (2007) AMER1 regulates the distribution of the tumor suppressor APC between microtubules and the plasma membrane. J. Cell Sci 120: 3738-3747. (Pubitemid 350187356)
37. Nakagawa H, Murata Y, Koyama K, Fujiyama A, Miyoshi Y, et al. (1998) Identification of a brain-specific APC homologue, APCL, and its interaction with beta-catenin. Cancer Res 58: 5176-5181. (Pubitemid 28521179)
38. van Es JH, Kirkpatrick C, van de Wetering M, Molenaar M, Miles A, et al. (1999) Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor. Curr Biol 9: 105-108. (Pubitemid 29085389)
39. Jarrett CR, Blancato J, Cao T, Bressette DS, Cepeda M, et al. (2001) Human APC2 localisation and allelic imbalance. Cancer Res 61: 7978-7984. (Pubitemid 33050988)
40. Lee E, Salic A, Krüger R, Heinrich R, Kirschner MW (2003) The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol 1: e10.
41. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P (1998) Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 8: 573-581. (Pubitemid 28222891)
42. Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, et al. (1998) Axin, an inhibitor of the Wnt signalling pathway interacts with β-catenin, GSK-3β and APC and reduces the β-catenin level. Genes Cells 3: 395-403. (Pubitemid 28387083)
43. Faux MC, Coates JL, Catimel B, Cody S, Clayton AH, et al. (2008) Recruitment of adenomatous polyposis coli and beta-catenin to Axin-puncta. Oncogene 27: 5808-5820.
44. Schwarz-Romond T, Fiedler M, Shibata N, Butler PJ, Kikuchi A, et al. (2007) The DIX domain of Dishevelled confers Wnt signaling by dynamic oligomerisation. Nat Struct Mol Biol 14: 484-492. (Pubitemid 46871810)
45. Mendoza-Topaz C, Mieszczanek J, Bienz M (2011) The Adenomatous polyposis coli tumour suppressor is essential for Axin complex assembly and function and opposes Axin's interaction with Dishevelled. Open Biol 1: e110013.
46. Fiedler M, Mendoza-Topaz C, Rutherford TJ, Mieszczanek J, Bienz M (2011) Dishevelled interacts with the DIX domain oligomerisation interface of Axin to interfere with its function in down-regulating β-catenin. Proc Natl Acad Sci USA 108: 1937-1942.
47. Yang J, Zhang W, Evans PM, Chen X, He X et al. (2006) Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem 281: 17751-17757. (Pubitemid 44035574)
48. Valvezan AJ, Zhang F, Diehl JA, Klein PS (2012) Adenomatous polyposis coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity. J Biol Chem 287: 3823-3832.
49. Tran H, Polakis P (2012) Reversible Modification of Adenomatous Polyposis Coli (APC) with K63-linked Polyubiquitin Regulates the Assembly and Activity of the β-Catenin Destruction Complex. J Biol Chem 287: 28552-28563.
50. Fagotto F, Jho E, Zeng L, Kurth T, Joos T, et al. (1999) Domains of Axin involved in protein-protein interactions, Wnt pathway inhibition, and Intracellular localisation. J Cell Biol 145: 741-756. (Pubitemid 29240852)
51. Smalley MJ, Sara E, Paterson H, Naylor S, Cook D, et al. (1999) Interaction of Axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription. EMBO J 18: 2823-2835. (Pubitemid 29233954)
52. Levina E, Oren M, Ben-Ze'evA (2004) Downregulation of betacatenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics. Oncogene 23: 4444-4453. (Pubitemid 38850423)
53. Wiechens N, Heinle K, Englmeier L, Schohl A, Fagotto F (2004) Nucleo-cytoplasmic shuttling of Axin, a negative regulator of the Wnt-beta-catenin Pathway. J Biol Chem 279: 5263-5267. (Pubitemid 38220546)
54. Munemitsu S, Souza B, Müller O, Albert I, Rubinfeld B, et al. (1994) The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 54: 3676-3681. (Pubitemid 24241177)
55. Mogensuen MM, Tucker JB, Mackie JB, Prescott AR, Näthke IS (2002) The adenomatous polyposis coli protein unambiguously localises to microtubule plus ends and is involved in establishing parallel arrays of microtubule bundles in highly polarized epithelial cells. J Cell Biol 157: 1041-1048. (Pubitemid 34839778)
56. Nakamura N, Rabouille C, Watson R, Nilsson T, Hui N, et al. (1995) Characterization of a cis-Golgi matrix protein, GM130. J Cell Biol. 131: 1715-26. (Pubitemid 26007969)
57. Linstedt AD, Hauri HP (1993) Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa. Mol Biol Cell 4: 679-93. (Pubitemid 23227154)
58. Prescott AR, Lucocq JM, James J, Lister JM, Ponnambalam S (1997) Distinct compartmentalization of TGN46 and beta 1,4-galactosyltransferase in HeLa cells. Eur J Cell Biol 72: 238-46. (Pubitemid 27117130)
59. Schneikert J, Vijaya Chandra SH, Ruppert JG, Ray S, Wenzel EM et al. (2013) Functional comparison of human Adenomatous Polyposis Coli (APC) and APC-Like in targeting beta-catenin for degradation. PloS ONE, in press.
60. Krieghoff E, Behrens J, Mayr B (2006) Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J Cell Sci 119: 1453-1463.
61. Schneikert J, Grohmann A, Behrens J (2007) Truncated APC regulates the transcriptional activity of beta-catenin in a cell cycle dependent manner. Hum Mol Genet 16: 199-209. (Pubitemid 46179002)
62. Hinoi T, Yamamoto H, Kishida M, Takada S, Kishida S et al. (2000) Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin. J Biol Chem 275: 34399-34406.
63. Smits R, Kielman MF, Breukel C, Zurcher C, Neufeld K, et al. (1999) Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev 13: 1309-1321. (Pubitemid 29250198)
64. Gaspar C, Franken P, Molenaar L, Breukel C, van der Valk M, et al. (2009) A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis. PLoS Genet 5: e1000547.
65. Hernández AR, Klein AM, Kirschner MW (2012) Kinetic responses of β-catenin specify the sites of Wnt control. Science 338:1337-1340.
66. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, et al. (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/Axin2 in colorectal and liver tumors. Mol Cell Biol 22: 1184-1193. (Pubitemid 34094854)
67. Vijaya-Chandra SH, Wacker I, Appelt UK, Behrens J, Schneikert J (2012) A common role for various human truncated adenomatous polyposis coli isoforms in the control of Beta-catenin activity and cell proliferation. PLoS One 7: e34479.
68. Kadoya T, Kishida S, Fukui A, Hinoi T, Michiue T, et al. (2000) Inhibition of Wnt signaling pathway by a novel Axin-binding protein. J Biol Chem 275: 37030-37037. (Pubitemid 32002119)
69. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, et al. (1997) Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88: 789-799. (Pubitemid 27164267)
70. Staal FJ, Noort MM, Strous GJ, Clevers HC (2002) Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep 3: 63-68. (Pubitemid 34144817)
71. Behrens J, Birchmeier W, Goodman SL, Imhof BA (1985) Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. J Cell Biol 101: 1307-1315. (Pubitemid 16203747)